| 1 |
Novak D, Janota B, Hörmann AA, Sawicka A, Kroselj M, Hubalewska-dydejczyk A, Fani M, Mikolajczak R, Kolenc P, Decristoforo C, Garnuszek P. Development of the 99mTc-Labelled SST2 Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study. Pharmaceutics 2023;15:885. [DOI: 10.3390/pharmaceutics15030885] [Reference Citation Analysis]
|
| 2 |
Makris G, Li Y, Gallazzi F, Kuchuk M, Wang J, Lewis MR, Jurisson SS, Hennkens HM. Evaluation of Re/99mTc-labeled somatostatin receptor-targeting peptide complexes synthesized via direct metal cyclization. Radiochimica Acta 2023;0. [DOI: 10.1515/ract-2022-0097] [Reference Citation Analysis]
|
| 3 |
Kunert JP, Müller M, Günther T, Stopper L, Urtz-Urban N, Beck R, Wester HJ. Synthesis and preclinical evaluation of novel (99m)Tc-labeled PSMA ligands for radioguided surgery of prostate cancer. EJNMMI Res 2023;13:2. [PMID: 36645586 DOI: 10.1186/s13550-022-00942-7] [Reference Citation Analysis]
|
| 4 |
Günther T, Konrad M, Stopper L, Kunert JP, Fischer S, Beck R, Casini A, Wester HJ. Optimization of the Pharmacokinetic Profile of [(99m)Tc]Tc-N(4)-Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence. Pharmaceuticals (Basel) 2022;15. [PMID: 36145354 DOI: 10.3390/ph15091133] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 5 |
Holik HA, Ibrahim FM, Elaine AA, Putra BD, Achmad A, Kartamihardja AHS. The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker. Molecules 2022;27:3062. [PMID: 35630536 DOI: 10.3390/molecules27103062] [Reference Citation Analysis]
|
| 6 |
Fani M, Mansi R, Nicolas GP, Wild D. Radiolabeled Somatostatin Analogs-A Continuously Evolving Class of Radiopharmaceuticals. Cancers (Basel) 2022;14:1172. [PMID: 35267479 DOI: 10.3390/cancers14051172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Gaonkar RH, Wiesmann F, Del Pozzo L, McDougall L, Zanger S, Mikołajczak R, Mansi R, Fani M. SPECT Imaging of SST2-Expressing Tumors with 99mTc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers. Pharmaceuticals (Basel) 2021;14:300. [PMID: 33800582 DOI: 10.3390/ph14040300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Mikulová MB, Mikuš P. Advances in Development of Radiometal Labeled Amino Acid-Based Compounds for Cancer Imaging and Diagnostics. Pharmaceuticals (Basel) 2021;14:167. [PMID: 33669938 DOI: 10.3390/ph14020167] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Maina T, Thakur M. SPECT Radiochemistry. Molecular Imaging 2021. [DOI: 10.1016/b978-0-12-816386-3.00023-5] [Reference Citation Analysis]
|
| 10 |
Fani M, Weingaertner V, Kolenc Peitl P, Mansi R, Gaonkar RH, Garnuszek P, Mikolajczak R, Novak D, Simoncic U, Hubalewska-Dydejczyk A, Rangger C, Kaeopookum P, Decristoforo C. Selection of the First 99mTc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation-Preclinical Assessment of Two Optimized Candidates. Pharmaceuticals (Basel) 2020;14:19. [PMID: 33379299 DOI: 10.3390/ph14010019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 11 |
Eychenne R, Bouvry C, Bourgeois M, Loyer P, Benoist E, Lepareur N. Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy. Molecules 2020;25:E4012. [PMID: 32887456 DOI: 10.3390/molecules25174012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 12 |
Duatti A. Review on 99mTc radiopharmaceuticals with emphasis on new advancements. Nucl Med Biol 2021;92:202-16. [PMID: 32475681 DOI: 10.1016/j.nucmedbio.2020.05.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 13 |
Oroujeni M, Garousi J, Andersson KG, Löfblom J, Mitran B, Orlova A, Tolmachev V. Preclinical Evaluation of [68Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors. Cells 2018;7:E141. [PMID: 30231504 DOI: 10.3390/cells7090141] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
